EQUILLIUM, INC. Capital Expenditures Incurred but Not yet Paid
EQUILLIUM, INC. (EQ) reported Capital Expenditures Incurred but Not yet Paid of $71.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-13
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $71.00K.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $59.00K.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-03-31 was $36.00K.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for the quarter ending 2019-03-31 was $13.00K, a 116.67% increase year-over-year.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $14.00K.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for fiscal 2019 was $11.00K, a 66.67% decline from fiscal 2018.
- EQUILLIUM, INC. capital expenditures incurred but not yet paid for fiscal 2018 was $33.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $71.00K 10-Q · filed 2026-05-13 | ||||
| 2024-03-31 | $59.00K 10-Q · filed 2025-05-14 | ||||
| 2022-03-31 | $36.00K 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | $14.00K 10-K · filed 2023-03-23 | ||||
| 2021-06-30 | $25.00K 10-Q · filed 2021-08-10 | ||||
| 2019-12-31 | $11.00K 10-K · filed 2021-03-24 | ||||
| 2019-03-31 | $13.00K 10-Q · filed 2020-05-13 | $37.86K derived: sum of 2 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $24.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $33.00K 10-K · filed 2020-03-26 | $32.68K 10-K · filed 2019-03-27 | ||
| 2018-09-30 | $8.14K 10-Q · filed 2018-11-15 | ||||
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |